Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2005

01-07-2005

On the role of melatonin in skin physiology and pathology

Authors: Andrzej Slominski, MD. PhD, Tobias W. Fischer, Michal A. Zmijewski, Jacobo Wortsman, Igor Semak, Blazaj Zbytek, Radomir M. Slominski, Desmond J. Tobin

Published in: Endocrine | Issue 2/2005

Login to get access
Metadata
Title
On the role of melatonin in skin physiology and pathology
Authors
Andrzej Slominski, MD. PhD
Tobias W. Fischer
Michal A. Zmijewski
Jacobo Wortsman
Igor Semak
Blazaj Zbytek
Radomir M. Slominski
Desmond J. Tobin
Publication date
01-07-2005
Publisher
Humana Press
Published in
Endocrine / Issue 2/2005
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:27:2:137

Other articles of this Issue 2/2005

Endocrine 2/2005 Go to the issue

OriginalPaper

Putting cancer to sleep at night

OriginalPaper

Metabolic effects of melatonin on odative stress and dbetes mellitus

OriginalPaper

Melatonin and parkinson’s disease

ReviewPaper

A review of the multiple actions of melatonin on the immune system

OriginalPaper

The rhythm and blues of gene expression in the rodent pineal gland

OriginalPaper

Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits